Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Jul 08, 2024 3:12pm
126 Views
Post# 36123232

For those who denigrate Alvira M. partners with Ascend 7M0

For those who denigrate Alvira M. partners with Ascend 7M0
For those who denigrate Dr. Adams and Alvira...the best ones who think they know everything, have been here for years crying about Ventripoint.
Thank you Alvira for this great success with Ascend Cardivascular.
Ventripoint Diagnostics Ltd. partners with ASCEND Cardiovascular on #AI based cardiovascular solutions. #medtech #healthtech #cardiology #investing
Ventripoint Diagnostics Ltd.
Ventripoint Announces Collaboration with Ascend Cardiovascular
thenewswire.com
Alvira Macanovic 7 months ago
I’m excited to share the news of our new global distribution and marketing agreement with ASCEND Cardiovascular, one of the most respected leaders in cardiac diagnostic care. This partnership marks a significant milestone in bringing our AI-powered heart-scanning technology, which transforms ultrasound images into MRI-quality heart scans, to healthcare facilities across North America.
 
What This Partnership Means:
Integration with Top-tier Technology: ASCEND Cardiovascular, renowned for its cardiovascular procedure and reporting solutions, will integrate Ventripoint’s technology into its expansive IT platform, already a staple used by 50,000 hospitals, clinics, and caregivers.
Wider Access: Our VMS+ system, which transforms ultrasound images into MRI-quality heart images, will now be more accessible to cardiologists and healthcare professionals.
Joint Efforts in Healthcare Innovation: Together with ASCEND, we aim to enhance cardiac care, reduce diagnostic times, and improve overall patient outcomes.
 
Key Highlights:
Initial Two-Year Term: Focused on the North American markets, this agreement sets the stage for broader, global impacts in the future.
Expert Collaboration: With ASCEND’s expertise in healthcare IT and our innovative heart-imaging technology, we are set to transform cardiac diagnostics.
From Jeffrey Soble, MD, President & CEO of ASCEND: “Our aim is to provide clinicians with reliable and effective tools on a global scale.”
Stay tuned for more updates on this exciting collaboration!
#VentripointDiagnostics #ASCENDCardiovascular #HealthcareInnovation #CardiacCare #AIMedicalTechnology
like 59
<< Previous
Bullboard Posts
Next >>